Wednesday, July 8, 2026

biotech · Clostridium Difficile Infection · Autism Spectrum Disorder · FNCHQ

Finch Therapeutics Group

Finch Therapeutics Group drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Somerville, USA HQ
15 Employees
Public company Type
FNCHQ · NYSE Ticker
Company details
Status
Public
HQ
Somerville, USA
Employees
15
Programs
5
Drugs
2
Patents
33
Intelligence · Drug Pipeline

Finch Therapeutics Group pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Finch Therapeutics Group drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to Finch Therapeutics Group in public FDA and regional records.

  2. Development asset linked to Finch Therapeutics Group in public FDA and regional records.